Loading
Loading…
Loading…
Ref. No.
Eligibility, documents, scope and key termsEligibility, required documents, scope of work and key terms of this tender, in one click.
Tender Value
Refer Docs
EMD Value
Exempted
Closing Date
25 Jul 2025, 11:00 amClosed
Eligibility, documents, scope and key termsEligibility, required documents, scope of work and key terms of this tender, in one click.
Inj Ocrelizumab 300 mg/10 ml
Inj Ofatumumab 20 mg
7889191
GEM/2025/B/6274971
Two Packet Bid
Inj Ocrelizumab 300 mg/10 ml
30 days
Kolkata
Item wise evaluation
PRODUCT_CUSTOM
7 documents required · 7 mandatory
2 yrs
₹11 L
₹11 L
20%
Exempted
25 Jul 2025
15 Jul 2025
25 Jul 2025
Inj Ocrelizumab 300 mg/10 ml
Inj Ofatumumab 20 mg
Inj Ofatumumab 20 mg
Tap a document below to read it instantly. You can also download everything as a ZIP if you prefer.
bid_7889191.pdf
GEM_BID
origin89_-2_2025-05-26-14-35-38_79f00f22a8fa37ac4b99795ca0ef5a2a.pdf
SPECIFICATION
origin89_-2_2025-05-26-14-38-25_068a1771ae654c0d19917430aa5bb2e5.pdf
SPECIFICATION
Origin89_5b739dc4-bc95-41c2-85261748251131365_Buyer2CHEC.docx
OTHER
list-of-categories-where-trials-are-allowed_1712126171.pdf
OTHER
gtc.pdf
OTHER
Download all tender documents and submit your bid
Disclaimer: TenderKart has made every reasonable effort to ensure that the information on this page is accurate and authentic, however it cannot be held liable for any third-party claims or losses or any damages. TenderKart makes no warranty, expressed or implied, as to the results obtained from the use of this information. If you notice any error or omission, please let us know at .